Spinal Canal

  • 3E0R Spinal Canal
    • 3E0R0 Open
      • 3E0R0A Stem Cells, Embryonic
        • 3E0R0AZ Introduction of Embryonic Stem Cells into Spinal Canal, Open Approach
      • 3E0R0E Stem Cells, Somatic
        • 3E0R0E0 Introduction of Autologous Somatic Stem Cells into Spinal Canal, Open Approach
        • 3E0R0E1 Introduction of Nonautologous Somatic Stem Cells into Spinal Canal, Open Approach
    • 3E0R3 Percutaneous
      • 3E0R30 Antineoplastic
        • 3E0R302 Introduction of High-dose Interleukin-2 into Spinal Canal, Percutaneous Approach
        • 3E0R303 Introduction of Low-dose Interleukin-2 into Spinal Canal, Percutaneous Approach
        • 3E0R304 Introduction of Liquid Brachytherapy Radioisotope into Spinal Canal, Percutaneous Approach
        • 3E0R305 Introduction of Other Antineoplastic into Spinal Canal, Percutaneous Approach
        • 3E0R30M Introduction of Antineoplastic, Monoclonal Antibody, into Spinal Canal, Percutaneous Approach
      • 3E0R32 Anti-infective
        • 3E0R328 Introduction of Oxazolidinones into Spinal Canal, Percutaneous Approach
        • 3E0R329 Introduction of Other Anti-infective into Spinal Canal, Percutaneous Approach
      • 3E0R33 Anti-inflammatory
        • 3E0R33Z Introduction of Anti-inflammatory into Spinal Canal, Percutaneous Approach
      • 3E0R36 Nutritional Substance
        • 3E0R36Z Introduction of Nutritional Substance into Spinal Canal, Percutaneous Approach
      • 3E0R37 Electrolytic and Water Balance Substance
        • 3E0R37Z Introduction of Electrolytic and Water Balance Substance into Spinal Canal, Percutaneous Approach
      • 3E0R3A Stem Cells, Embryonic
        • 3E0R3AZ Introduction of Embryonic Stem Cells into Spinal Canal, Percutaneous Approach
      • 3E0R3B Anesthetic Agent
        • 3E0R3BZ Introduction of Anesthetic Agent into Spinal Canal, Percutaneous Approach
      • 3E0R3E Stem Cells, Somatic
        • 3E0R3E0 Introduction of Autologous Somatic Stem Cells into Spinal Canal, Percutaneous Approach
        • 3E0R3E1 Introduction of Nonautologous Somatic Stem Cells into Spinal Canal, Percutaneous Approach
      • 3E0R3G Other Therapeutic Substance
        • 3E0R3GC Introduction of Other Therapeutic Substance into Spinal Canal, Percutaneous Approach
      • 3E0R3H Radioactive Substance
        • 3E0R3HZ Introduction of Radioactive Substance into Spinal Canal, Percutaneous Approach
      • 3E0R3K Other Diagnostic Substance
        • 3E0R3KZ Introduction of Other Diagnostic Substance into Spinal Canal, Percutaneous Approach
      • 3E0R3N Analgesics, Hypnotics, Sedatives
        • 3E0R3NZ Introduction of Analgesics, Hypnotics, Sedatives into Spinal Canal, Percutaneous Approach
      • 3E0R3S Gas
        • 3E0R3SF Introduction of Other Gas into Spinal Canal, Percutaneous Approach
      • 3E0R3T Destructive Agent
        • 3E0R3TZ Introduction of Destructive Agent into Spinal Canal, Percutaneous Approach
    • 3E0R7 Via Natural or Artificial Opening
      • 3E0R7S Gas
        • 3E0R7SF Introduction of Other Gas into Spinal Canal, Via Natural or Artificial Opening